TGF-β’s pleiotropic functions and widespread tissue expression enables further consequences from disrupted TGF-β signaling: pathogenic immune response, cancer, abnormal wound healing, neurodegenerative diseases, pulmonary hypertension and renal and cardiac fibrosis [33]. Here, TGFB1 is linked to pulmonary arterial hypertension.